What to Expect: Nurtec ODT, Ubrelvy, Qulipta & Zavzpret

Key Questions
  • What are CGRP small-molecule receptor antagonists (gepants)?
  • How are gepants different from CGRP monoclonal antibodies?
  • At what stage of a migraine attack should a gepant be taken?
  • What gepants are currently available and how do they differ from each other?
  • What are the doses and administration for each gepant?
  • How does a doctor decide which gepant to try for each patient?
  • How do gepants differ from triptans?
  • What are some other options for patients who don’t respond to gepants?
  • Are gepants effective for both episodic and chronic migraine?
  • Can gepants be taken while pregnant or breastfeeding?
  • Are there any drug interactions and/or risks associated with gepants?
  • Can gepants be used to treat migraine in children or adolescents?

Matthew Robbins, MD

Associate Professor of Neurology and Residency Program Director
Weill Cornell Medicine, New York-Presbyterian Hospital

Matthew S. Robbins, M.D., is the program director for the neurology residency and an associate professor of neurology at Weill Cornell Medicine and New York-Presbyterian Hospital. His clinical practice focuses on patients with migraine, cluster headache, new daily persistent headache, other headache disorders, CSF (cerebrospinal fluid) leaks, and visual snow. He has experience with patient care, teaching, and research for headache disorder treatments, including monoclonal antibodies, procedures such as botulinum toxin injections and peripheral nerve blocks, and neuromodulation devices. Dr. Robbins developed an academic career integrating patient care, education and mentorship, research, and advocacy for people with headache and other neurological conditions.

Previously, Dr. Robbins earned his B.S. from Yale University and his M.D. from SUNY-Downstate College of Medicine. He completed his neurology residency at the Albert Einstein College of Medicine/Montefiore Medical Center, where he was also a chief resident and then a Fellow in Headache Medicine at the Montefiore Headache Center. He served on the faculty at Montefiore-Einstein for nearly a decade, where he was an associate professor of neurology, chief of neurology at the Jack D. Weiler Hospital, and director of inpatient services for the Montefiore Headache Center.

He serves as president-elect of the New York Neurological Society and on the board of directors of the American Headache Society. In addition, he is passionate about advocacy, and is a graduate of the Palatucci Advocacy Leadership Forum of the American Academy of Neurology.

Pre-purchase full access to the entire 2024 Summit, including:

  • All expert interviews with separate audio (MP3) files & transcripts
  • 30 extended, uncut interview editions with hours more expert footage
  • Lifetime access with no annual fee
Order your 2024 Access Pass

Related Talks for: Day 4 (2024)

New Daily Persistent Headache: Pain That Won’t Stop

Andrew D. Hershey MD, PhD, FAAN, FAHS

The Nervous System, Stored Trauma & Migraine

Aimie Apigian, MD, MS, MPH

When Headache Starts Behind the Eyes

Deborah Friedman, MD, MPH, FAAN, FAHS

Leave a comment

Back to top